MYLAN ApS: Financial statements 2021
CVR: 28107013
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
MYLAN ApS (CVR 28107013) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 5,388 and a net result of DKK 2,086 compared with DKK 2,079 the year before. That is an increase of 4.1% compared with the year before. Equity in the 2021 report amounted to DKK 193,839. The solvency ratio was 51.2%.
- Gross Profit
- DKK 5,388
- Profit/Loss
- DKK 2,086
- Equity
- DKK 193,839
- Total Assets
- DKK 378,399
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 5 t. | 2 t. | 194 t. | 0 |
| 2020 | - | 5 t. | 2 t. | 192 t. | 0 |
| 2019 | - | 5 t. | 2 t. | 190 t. | 0 |
| 2018 | - | 3 t. | 1 t. | 188 t. | 0 |
| 2017 | - | 2 t. | 2 t. | 186 t. | 0 |
Find more companies like MYLAN ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
MYLAN ApS has published its annual report for 2020. Gross profit came to DKK 5,178, and the net result was DKK 2,079.
As of February 8, 2021, Luis Rodolfo Birbuet has joined the board of directors of MYLAN ApS.
As of February 8, 2021, Jose Javier Cotarelo has left the board of directors of MYLAN ApS.
About MYLAN ApS
MYLAN ApS was a Danish company of the type Anpartsselskab based in Ballerup, founded in 2004. The company has been dissolved. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERCK NM ApS and NM PHARMA ApS. According to the 2022 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK 3,631 and a net result of DKK 3,137 compared with DKK 1,952 the year before. Equity in the 2024 report amounted to DKK 198,978.